Concepts (254)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart-Assist Devices | 64 | 2026 | 1020 | 6.020 |
Why?
|
| Heart Failure | 48 | 2026 | 2332 | 3.520 |
Why?
|
| Heart Transplantation | 13 | 2024 | 800 | 1.220 |
Why?
|
| Prosthesis Implantation | 10 | 2024 | 152 | 0.940 |
Why?
|
| Intensive Care Units | 1 | 2026 | 526 | 0.730 |
Why?
|
| Ventricular Function, Left | 7 | 2024 | 549 | 0.720 |
Why?
|
| Shock, Cardiogenic | 8 | 2022 | 176 | 0.680 |
Why?
|
| Critical Care | 1 | 2026 | 686 | 0.640 |
Why?
|
| Thrombosis | 2 | 2022 | 499 | 0.640 |
Why?
|
| Heart Valve Prosthesis Implantation | 5 | 2022 | 425 | 0.560 |
Why?
|
| Gastrointestinal Hemorrhage | 4 | 2026 | 239 | 0.550 |
Why?
|
| Kidney Transplantation | 1 | 2023 | 558 | 0.520 |
Why?
|
| Retrospective Studies | 42 | 2026 | 17753 | 0.500 |
Why?
|
| Heart Ventricles | 10 | 2021 | 749 | 0.460 |
Why?
|
| Tissue and Organ Procurement | 3 | 2023 | 254 | 0.400 |
Why?
|
| Treatment Outcome | 29 | 2024 | 12936 | 0.400 |
Why?
|
| Humans | 82 | 2026 | 131163 | 0.390 |
Why?
|
| Middle Aged | 44 | 2026 | 28601 | 0.380 |
Why?
|
| Postoperative Complications | 8 | 2020 | 3147 | 0.380 |
Why?
|
| Waiting Lists | 4 | 2023 | 253 | 0.380 |
Why?
|
| Ventricular Dysfunction, Left | 4 | 2021 | 362 | 0.370 |
Why?
|
| Percutaneous Coronary Intervention | 3 | 2022 | 299 | 0.340 |
Why?
|
| Vascular Resistance | 2 | 2024 | 182 | 0.330 |
Why?
|
| Aged | 32 | 2026 | 21025 | 0.330 |
Why?
|
| Pulmonary Artery | 3 | 2024 | 434 | 0.320 |
Why?
|
| Hemodynamics | 7 | 2021 | 810 | 0.320 |
Why?
|
| Prosthesis-Related Infections | 2 | 2025 | 197 | 0.310 |
Why?
|
| Device Removal | 4 | 2021 | 225 | 0.310 |
Why?
|
| Male | 52 | 2026 | 64957 | 0.300 |
Why?
|
| Aortic Valve Insufficiency | 3 | 2019 | 149 | 0.290 |
Why?
|
| Thoracic Surgical Procedures | 2 | 2023 | 105 | 0.290 |
Why?
|
| Incidental Findings | 1 | 2009 | 122 | 0.270 |
Why?
|
| Tachycardia, Ventricular | 2 | 2024 | 257 | 0.270 |
Why?
|
| Catheter Ablation | 2 | 2024 | 324 | 0.260 |
Why?
|
| Heart, Artificial | 2 | 2018 | 46 | 0.260 |
Why?
|
| Time Factors | 15 | 2024 | 6196 | 0.250 |
Why?
|
| Female | 48 | 2026 | 70963 | 0.240 |
Why?
|
| Myocarditis | 2 | 2018 | 122 | 0.240 |
Why?
|
| Angioplasty, Balloon, Coronary | 5 | 2009 | 161 | 0.240 |
Why?
|
| Aorta | 2 | 2020 | 521 | 0.230 |
Why?
|
| Thromboembolism | 1 | 2026 | 93 | 0.220 |
Why?
|
| Registries | 6 | 2022 | 1634 | 0.220 |
Why?
|
| Heart Defects, Congenital | 3 | 2024 | 1889 | 0.220 |
Why?
|
| Heart Valve Diseases | 2 | 2019 | 162 | 0.220 |
Why?
|
| Risk Factors | 16 | 2026 | 11074 | 0.220 |
Why?
|
| Physicians | 2 | 2024 | 635 | 0.210 |
Why?
|
| Multiple Organ Failure | 1 | 2006 | 145 | 0.210 |
Why?
|
| Extracorporeal Membrane Oxygenation | 2 | 2021 | 682 | 0.210 |
Why?
|
| Proportional Hazards Models | 7 | 2025 | 1410 | 0.210 |
Why?
|
| Acute Kidney Injury | 3 | 2022 | 705 | 0.210 |
Why?
|
| Cardiomyopathies | 2 | 2021 | 514 | 0.200 |
Why?
|
| Aorta, Thoracic | 1 | 2009 | 530 | 0.200 |
Why?
|
| Survival Rate | 9 | 2020 | 2114 | 0.200 |
Why?
|
| Adult | 24 | 2025 | 31282 | 0.200 |
Why?
|
| Cardiac Surgical Procedures | 4 | 2020 | 1168 | 0.190 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2024 | 178 | 0.180 |
Why?
|
| Kidney | 3 | 2024 | 1282 | 0.180 |
Why?
|
| Equipment Failure | 3 | 2018 | 122 | 0.180 |
Why?
|
| Aortic Valve Stenosis | 1 | 2006 | 350 | 0.180 |
Why?
|
| Hyponatremia | 1 | 2022 | 73 | 0.170 |
Why?
|
| Aortic Valve | 4 | 2013 | 455 | 0.160 |
Why?
|
| Glucosides | 1 | 2021 | 55 | 0.160 |
Why?
|
| Anticoagulants | 2 | 2022 | 605 | 0.160 |
Why?
|
| Tissue Donors | 2 | 2023 | 506 | 0.160 |
Why?
|
| Benzhydryl Compounds | 1 | 2021 | 79 | 0.160 |
Why?
|
| Health Literacy | 1 | 2021 | 77 | 0.160 |
Why?
|
| Severity of Illness Index | 4 | 2024 | 3061 | 0.160 |
Why?
|
| Nephrology | 1 | 2022 | 162 | 0.150 |
Why?
|
| Plasmapheresis | 1 | 2019 | 30 | 0.150 |
Why?
|
| Heart Arrest, Induced | 1 | 2020 | 75 | 0.150 |
Why?
|
| Cause of Death | 2 | 2018 | 506 | 0.150 |
Why?
|
| Kaplan-Meier Estimate | 5 | 2024 | 1071 | 0.150 |
Why?
|
| Renal Replacement Therapy | 1 | 2021 | 172 | 0.150 |
Why?
|
| Mitral Valve Annuloplasty | 1 | 2019 | 15 | 0.140 |
Why?
|
| Patient Selection | 2 | 2020 | 729 | 0.140 |
Why?
|
| Survival Analysis | 5 | 2022 | 1483 | 0.140 |
Why?
|
| Prosthesis Failure | 2 | 2017 | 159 | 0.140 |
Why?
|
| Heart Valves | 1 | 2019 | 52 | 0.140 |
Why?
|
| Myocardial Ischemia | 1 | 2021 | 307 | 0.140 |
Why?
|
| Transducers, Pressure | 1 | 2018 | 10 | 0.140 |
Why?
|
| Blood Pressure Monitors | 1 | 2018 | 4 | 0.140 |
Why?
|
| Hypoalbuminemia | 1 | 2018 | 16 | 0.140 |
Why?
|
| Incidence | 7 | 2020 | 3360 | 0.140 |
Why?
|
| Transplant Recipients | 1 | 2020 | 235 | 0.140 |
Why?
|
| Heart | 1 | 2023 | 650 | 0.140 |
Why?
|
| Renal Insufficiency | 1 | 2021 | 259 | 0.140 |
Why?
|
| Heparin | 1 | 2019 | 208 | 0.140 |
Why?
|
| Arterial Switch Operation | 1 | 2018 | 23 | 0.140 |
Why?
|
| Ventricular Function | 2 | 2019 | 81 | 0.140 |
Why?
|
| Serum Albumin | 1 | 2018 | 101 | 0.140 |
Why?
|
| International Normalized Ratio | 1 | 2018 | 44 | 0.140 |
Why?
|
| Sternotomy | 1 | 2018 | 41 | 0.130 |
Why?
|
| Organ Transplantation | 1 | 2020 | 175 | 0.130 |
Why?
|
| Thrombocytopenia | 1 | 2019 | 223 | 0.130 |
Why?
|
| Nervous System Diseases | 2 | 2018 | 395 | 0.130 |
Why?
|
| Prealbumin | 1 | 2017 | 27 | 0.130 |
Why?
|
| Obesity | 3 | 2018 | 2426 | 0.130 |
Why?
|
| Body Size | 1 | 2017 | 62 | 0.130 |
Why?
|
| Decision Making | 2 | 2024 | 726 | 0.130 |
Why?
|
| Reoperation | 1 | 2020 | 818 | 0.120 |
Why?
|
| Nutritional Status | 1 | 2018 | 298 | 0.120 |
Why?
|
| Cardiology | 1 | 2021 | 514 | 0.120 |
Why?
|
| Patient-Centered Care | 1 | 2018 | 236 | 0.120 |
Why?
|
| Eosinophilia | 1 | 2017 | 112 | 0.110 |
Why?
|
| Informed Consent | 1 | 2018 | 351 | 0.110 |
Why?
|
| End Stage Liver Disease | 1 | 2018 | 193 | 0.110 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2017 | 187 | 0.110 |
Why?
|
| Decision Support Techniques | 1 | 2018 | 293 | 0.110 |
Why?
|
| Malnutrition | 1 | 2017 | 163 | 0.110 |
Why?
|
| Texas | 6 | 2019 | 3686 | 0.110 |
Why?
|
| Equipment Design | 5 | 2021 | 512 | 0.100 |
Why?
|
| Cell-Derived Microparticles | 1 | 2014 | 26 | 0.100 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2017 | 482 | 0.100 |
Why?
|
| Transposition of Great Vessels | 1 | 2015 | 118 | 0.100 |
Why?
|
| Risk Assessment | 6 | 2024 | 3711 | 0.100 |
Why?
|
| Coronary Thrombosis | 1 | 2013 | 33 | 0.100 |
Why?
|
| Pandemics | 1 | 2020 | 1118 | 0.100 |
Why?
|
| Antithrombins | 1 | 2013 | 49 | 0.100 |
Why?
|
| Prognosis | 5 | 2021 | 4886 | 0.090 |
Why?
|
| Emergency Medical Services | 1 | 2016 | 352 | 0.090 |
Why?
|
| Fontan Procedure | 1 | 2015 | 180 | 0.090 |
Why?
|
| Recovery of Function | 3 | 2019 | 449 | 0.090 |
Why?
|
| Young Adult | 7 | 2024 | 10103 | 0.090 |
Why?
|
| Follow-Up Studies | 5 | 2024 | 5196 | 0.090 |
Why?
|
| Robotics | 2 | 1992 | 102 | 0.080 |
Why?
|
| Aortography | 2 | 2009 | 155 | 0.080 |
Why?
|
| Atrial Fibrillation | 1 | 2018 | 738 | 0.080 |
Why?
|
| Magnetic Resonance Angiography | 2 | 2009 | 161 | 0.080 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2012 | 161 | 0.080 |
Why?
|
| Peptide Fragments | 1 | 2013 | 687 | 0.080 |
Why?
|
| Wounds and Injuries | 1 | 2013 | 398 | 0.080 |
Why?
|
| Prosthesis Design | 3 | 2018 | 643 | 0.070 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2009 | 371 | 0.070 |
Why?
|
| United States | 6 | 2023 | 12072 | 0.070 |
Why?
|
| Cardiovascular Diseases | 1 | 2021 | 2121 | 0.070 |
Why?
|
| Preoperative Period | 2 | 2018 | 90 | 0.070 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2009 | 229 | 0.060 |
Why?
|
| Databases, Factual | 2 | 2024 | 1240 | 0.060 |
Why?
|
| Intra-Aortic Balloon Pumping | 2 | 2022 | 42 | 0.060 |
Why?
|
| Myocardial Infarction | 1 | 2013 | 999 | 0.060 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2017 | 2065 | 0.060 |
Why?
|
| Sequence Analysis, DNA | 1 | 1992 | 1692 | 0.060 |
Why?
|
| Echocardiography | 4 | 2017 | 1125 | 0.060 |
Why?
|
| Takayasu Arteritis | 1 | 2006 | 13 | 0.060 |
Why?
|
| Arrhythmogenic Right Ventricular Dysplasia | 1 | 2006 | 18 | 0.060 |
Why?
|
| Coronary Stenosis | 1 | 2006 | 78 | 0.050 |
Why?
|
| Attitude | 1 | 2024 | 111 | 0.050 |
Why?
|
| Multivariate Analysis | 2 | 2018 | 1378 | 0.050 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2024 | 77 | 0.050 |
Why?
|
| Policy | 1 | 2023 | 39 | 0.050 |
Why?
|
| Stents | 2 | 2006 | 799 | 0.050 |
Why?
|
| Phenylephrine | 1 | 2022 | 35 | 0.050 |
Why?
|
| Coronary Disease | 1 | 2006 | 624 | 0.050 |
Why?
|
| Predictive Value of Tests | 2 | 2018 | 2304 | 0.050 |
Why?
|
| Logistic Models | 2 | 2018 | 1797 | 0.040 |
Why?
|
| Multicenter Studies as Topic | 1 | 2022 | 294 | 0.040 |
Why?
|
| Coronary Artery Disease | 1 | 2009 | 887 | 0.040 |
Why?
|
| Cardiac Tamponade | 1 | 2002 | 35 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2025 | 1490 | 0.040 |
Why?
|
| Fatal Outcome | 2 | 2018 | 352 | 0.040 |
Why?
|
| Pharmacogenomic Testing | 1 | 2021 | 47 | 0.040 |
Why?
|
| Prospective Studies | 3 | 2022 | 6459 | 0.040 |
Why?
|
| Tracheostomy | 1 | 2023 | 212 | 0.040 |
Why?
|
| Heart Neoplasms | 1 | 2002 | 106 | 0.040 |
Why?
|
| Patient Education as Topic | 1 | 2024 | 464 | 0.040 |
Why?
|
| Hypoxanthine Phosphoribosyltransferase | 2 | 1990 | 34 | 0.040 |
Why?
|
| Pharmacogenetics | 1 | 2021 | 201 | 0.040 |
Why?
|
| Constriction | 1 | 2020 | 46 | 0.040 |
Why?
|
| Sex Factors | 1 | 2024 | 1356 | 0.040 |
Why?
|
| Arteriovenous Malformations | 1 | 2020 | 49 | 0.040 |
Why?
|
| Aged, 80 and over | 4 | 2018 | 6797 | 0.040 |
Why?
|
| Motivation | 1 | 2021 | 328 | 0.040 |
Why?
|
| Hospital Mortality | 1 | 2023 | 1064 | 0.030 |
Why?
|
| Diastole | 1 | 2019 | 181 | 0.030 |
Why?
|
| Biomarkers | 2 | 2018 | 3385 | 0.030 |
Why?
|
| Body Mass Index | 2 | 2018 | 1717 | 0.030 |
Why?
|
| Base Sequence | 5 | 1994 | 2730 | 0.030 |
Why?
|
| Ventricular Function, Right | 1 | 2018 | 126 | 0.030 |
Why?
|
| Molecular Sequence Data | 5 | 1994 | 3464 | 0.030 |
Why?
|
| Adolescent | 3 | 2024 | 20987 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2021 | 1626 | 0.030 |
Why?
|
| Punctures | 1 | 2017 | 52 | 0.030 |
Why?
|
| Comorbidity | 2 | 2016 | 1595 | 0.030 |
Why?
|
| Prostheses and Implants | 1 | 2018 | 146 | 0.030 |
Why?
|
| Morbidity | 1 | 2017 | 256 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2018 | 321 | 0.030 |
Why?
|
| Heart Valve Prosthesis | 1 | 2019 | 303 | 0.030 |
Why?
|
| Deoxyribonucleotides | 1 | 1994 | 7 | 0.030 |
Why?
|
| Melanoma | 1 | 2002 | 931 | 0.030 |
Why?
|
| Renal Dialysis | 1 | 2022 | 951 | 0.030 |
Why?
|
| Genetic Testing | 1 | 2021 | 1106 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2006 | 3763 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 3 | 1992 | 1447 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2015 | 351 | 0.030 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 2 | 1991 | 330 | 0.020 |
Why?
|
| Hypertension, Pulmonary | 1 | 2018 | 457 | 0.020 |
Why?
|
| Hirudins | 1 | 2013 | 39 | 0.020 |
Why?
|
| Biopsy | 1 | 2017 | 1239 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2014 | 563 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2016 | 1216 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2014 | 905 | 0.020 |
Why?
|
| Bacteriophage M13 | 1 | 1992 | 17 | 0.020 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 1992 | 39 | 0.020 |
Why?
|
| Myocardium | 1 | 2017 | 852 | 0.020 |
Why?
|
| DNA | 2 | 1994 | 1399 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2020 | 3829 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2014 | 765 | 0.020 |
Why?
|
| DNA Fingerprinting | 1 | 1991 | 106 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2014 | 1211 | 0.020 |
Why?
|
| Exons | 2 | 1990 | 759 | 0.020 |
Why?
|
| Quality of Life | 1 | 2021 | 2082 | 0.020 |
Why?
|
| Lesch-Nyhan Syndrome | 1 | 1990 | 10 | 0.020 |
Why?
|
| Nucleotide Mapping | 1 | 1990 | 12 | 0.020 |
Why?
|
| DNA, Viral | 1 | 1992 | 448 | 0.020 |
Why?
|
| Stroke | 1 | 2018 | 1061 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2013 | 1319 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2014 | 1445 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 1991 | 1046 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2018 | 5063 | 0.020 |
Why?
|
| Polymorphism, Genetic | 1 | 1991 | 776 | 0.020 |
Why?
|
| Chromosome Deletion | 1 | 1990 | 653 | 0.020 |
Why?
|
| Stroke Volume | 1 | 2009 | 541 | 0.010 |
Why?
|
| Ventricular Dysfunction | 1 | 2006 | 24 | 0.010 |
Why?
|
| Dilatation, Pathologic | 1 | 2006 | 73 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2009 | 824 | 0.010 |
Why?
|
| Subclavian Artery | 1 | 2006 | 63 | 0.010 |
Why?
|
| Genome, Human | 1 | 1991 | 1321 | 0.010 |
Why?
|
| Fluoroscopy | 1 | 2005 | 108 | 0.010 |
Why?
|
| Sheep | 1 | 2005 | 229 | 0.010 |
Why?
|
| Coronary Angiography | 1 | 2006 | 450 | 0.010 |
Why?
|
| Myocardial Revascularization | 1 | 2004 | 100 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2008 | 1345 | 0.010 |
Why?
|
| Child | 1 | 2022 | 26341 | 0.010 |
Why?
|
| Pericardial Effusion | 1 | 2002 | 78 | 0.010 |
Why?
|
| Genes | 2 | 1990 | 308 | 0.010 |
Why?
|
| Heart Atria | 1 | 2002 | 343 | 0.010 |
Why?
|
| Electrocardiography | 1 | 2002 | 970 | 0.010 |
Why?
|
| Templates, Genetic | 1 | 1994 | 52 | 0.010 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 1994 | 87 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2005 | 4697 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1994 | 318 | 0.010 |
Why?
|
| Molecular Structure | 1 | 1994 | 315 | 0.010 |
Why?
|
| Fluorescence | 1 | 1991 | 94 | 0.010 |
Why?
|
| Chromosomes, Human | 1 | 1991 | 118 | 0.010 |
Why?
|
| X Chromosome | 1 | 1991 | 327 | 0.010 |
Why?
|
| DNA, Recombinant | 1 | 1990 | 71 | 0.000 |
Why?
|
| Genetic Carrier Screening | 1 | 1990 | 67 | 0.000 |
Why?
|
| Fluorometry | 1 | 1990 | 27 | 0.000 |
Why?
|
| Automation | 1 | 1990 | 65 | 0.000 |
Why?
|
| Heterozygote | 1 | 1991 | 737 | 0.000 |
Why?
|
| Pedigree | 1 | 1990 | 1677 | 0.000 |
Why?
|
| Amino Acid Sequence | 1 | 1990 | 2395 | 0.000 |
Why?
|
| Software | 1 | 1990 | 733 | 0.000 |
Why?
|
| Animals | 1 | 2005 | 33912 | 0.000 |
Why?
|